Central Hub for the European Union

Serbia has established a sophisticated pharmaceutical regulation system that prioritizes patient safety through advanced traceability measures and anti-counterfeiting protocols. Built upon the foundation of the Serbian Drugs Law of 1993 and aligned with European standards, Serbia's regulatory framework ensures comprehensive monitoring of pharmaceutical products from manufacturer to patient, creating a robust defense against falsified medicines while enabling rapid response capabilities.